This analysis focuses on the recent activities within Yacktman Asset Management's stock portfolio, as detailed in their quarterly 13F filings. In the third quarter of 2025, the overall value of the portfolio experienced a decrease, settling at $7.26 billion. The firm continued to manage a focused collection of 70 distinct holdings, with a substantial portion\u2014roughly 9%\u2014held in cash. This approach underscores Yacktman's commitment to a concentrated, value-oriented investment philosophy, which is evident in their strategic adjustments to key positions.
Yacktman Asset Management's Strategic Portfolio Shifts in Q3 2025
During the third quarter of 2025, Yacktman Asset Management made significant strategic moves within its investment portfolio, reflecting a disciplined approach to managing its holdings. The portfolio, primarily known for its value-driven and concentrated investment style, saw its total value slightly reduced to $7.26 billion, maintaining 70 positions alongside a notable 9% cash allocation.
A closer look at the top five holdings reveals the core of Yacktman's strategy: Canadian Natural Resources, Microsoft, Fox Corp., Charles Schwab, and Procter & Gamble. These five companies collectively constituted approximately 32% of the total portfolio value, indicating a strong conviction in these select entities. However, the quarter was marked by a strategic reduction in stakes across many of these prominent positions. Canadian Natural Resources, Microsoft, Fox Corp., Charles Schwab, and Procter & Gamble all experienced significant trimming, suggesting a methodical approach to profit-taking or risk management in light of market conditions or re-evaluated valuations.
Conversely, UnitedHealth emerged as a notable exception, being the only major holding where Yacktman opted to increase its stake. This move highlights a selective bullish outlook on the healthcare giant amidst a broader trend of portfolio recalibration. The ongoing adjustments within Yacktman's portfolio demonstrate a dynamic and responsive investment process, where careful consideration of market movements and fundamental valuations drives decisions to either scale back or selectively expand positions, all while maintaining a steadfast focus on long-term value generation and capital preservation.
From a journalist's perspective, Yacktman Asset Management's Q3 2025 portfolio adjustments offer valuable insights into the careful balance between value investing and dynamic market response. The decision to trim core holdings while selectively increasing a stake in UnitedHealth reflects a nuanced strategy rather than a blanket approach. It emphasizes the importance of continuous re-evaluation of positions, even those considered foundational, and the willingness to take profits and manage risk proactively. This disciplined methodology can inspire investors to critically assess their own portfolios, encouraging them to remain agile and thoughtful in their investment decisions, rather than holding onto assets passively. It's a reminder that successful investing often involves strategic exits as much as strategic entries.